Quality of Life in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Maintenance Chemotherapy

Description

The purpose of the study is to evaluate the impact of exercise on physical activity levels and quality of life in children with acute lymphoblastic leukemia (ALL) receiving maintenance chemotherapy.

Conditions

Quality of Life

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of the study is to evaluate the impact of exercise on physical activity levels and quality of life in children with acute lymphoblastic leukemia (ALL) receiving maintenance chemotherapy.

Physical Activity and Quality of Life in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Maintenance Chemotherapy

Quality of Life in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Maintenance Chemotherapy

Condition
Quality of Life
Intervention / Treatment

-

Contacts and Locations

Hartford

Connecticut Children's Medical Center, Hartford, Connecticut, United States, 06106

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Pediatric oncology patients with ALL in the maintenance phase of chemotherapy during the time of study
  • * Ages 8-18 years of either gender (age limits due to reliability and validity of outcome assessment surveys)
  • * Have no documented or observable psychiatric or neurological disorders that would interfere with study participation
  • * Capable of speaking and reading English
  • * Having no contraindications to participate in moderate physical exercise as determined by the research staff and the patient's pediatric oncologist
  • * Currently living with their parents/legal guardians
  • * Consent obtained from legal guardians and assent obtained from patients to participate in the study
  • * Not a pediatric oncology patient with ALL in maintenance
  • * Not receiving chemotherapy during the time of study
  • * Age less than 8 years or greater than 18 years
  • * Not English-speaking Since not all outcome measures have been validated in Spanish and other languages, only English-speaking patients will be included.

Ages Eligible for Study

8 Years to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Connecticut Children's Medical Center,

Andrea Orsey, MD, PRINCIPAL_INVESTIGATOR, Connecticut Children's Medical Center

Study Record Dates

2028-12